(RNO) Renault - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000131906
Stock:
Total Rating 29
Risk 74
Buy Signal -0.39
| Risk 5d forecast | |
|---|---|
| Volatility | 30.4% |
| Relative Tail Risk | -2.96% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.96 |
| Alpha | -43.94 |
| Character TTM | |
|---|---|
| Beta | 0.537 |
| Beta Downside | 0.997 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.68% |
| CAGR/Max DD | -0.03 |
Description: RNO Renault
Renault SA engages in the design, manufacture, sale, repair, maintenance, and leasing of motor vehicles in Europe, Eurasia, Africa, the Middle East, the Asia Pacific, and the Americas. The company operates through Automotive, Sales Financing, and Mobility Services segments. The Automotive segment produces, sells, and distributes passenger cars and light commercial vehicles. The Sale Financing segment is involved in the sales financing, rental, maintenance, and service contracts under the Mobilize Financial Services brand. The Mobility Services segment provides mobility and energy solutions for electric vehicle users under the Mobilize Beyond Automotive brand. In addition, it offers used vehicles and spare parts; and engages in the business-to-business powertrain activities, and research and advanced engineering activities. Further, the company engages in the design and production of parts and equipment used for manufacturing and operation of vehicles. It offers commercial, light commercial and passenger vehicles, tractors, farm machinery and construction equipment under the Renault, Dacia, Alpine, Renault Korea Motors, and the Mobilize brands. The company was founded in 1898 and is based in Boulogne-Billancourt, France.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: -10.09b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.38 > 1.0 |
| NWC/Revenue: 1.96% < 20% (prev 9.42%; Δ -7.45% < -1%) |
| CFO/TA 0.08 > 3% & CFO 9.94b > Net Income -10.09b |
| Net Debt (50.06b) to EBITDA (28.65b): 1.75 < 3 |
| Current Ratio: 1.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (281.7m) vs 12m ago -3.01% < -2% |
| Gross Margin: 18.89% > 18% (prev 0.19%; Δ 1871 % > 0.5%) |
| Asset Turnover: 93.98% > 50% (prev 73.18%; Δ 20.81% > 0%) |
| Interest Coverage Ratio: -10.90 > 6 (EBITDA TTM 28.65b / Interest Expense TTM 544.0m) |
Altman Z'' 0.46
| A: 0.02 (Total Current Assets 90.71b - Total Current Liabilities 88.47b) / Total Assets 121.01b |
| B: 0.15 (Retained Earnings 17.59b / Total Assets 121.01b) |
| C: -0.05 (EBIT TTM -5.93b / Avg Total Assets 121.46b) |
| D: 0.19 (Book Value of Equity 18.71b / Total Liabilities 100.22b) |
| Altman-Z'' Score: 0.46 = B |
Beneish M -3.33
| DSRI: 0.83 (Receivables 58.30b/54.83b, Revenue 114.15b/89.21b) |
| GMI: 1.00 (GM 18.89% / 18.86%) |
| AQI: 0.68 (AQ_t 0.13 / AQ_t-1 0.19) |
| SGI: 1.28 (Revenue 114.15b / 89.21b) |
| TATA: -0.17 (NI -10.09b - CFO 9.94b) / TA 121.01b) |
| Beneish M-Score: -3.33 (Cap -4..+1) = AA |
What is the price of RNO shares?
As of February 27, 2026, the stock is trading at EUR 32.43 with a total of 1,235,437 shares traded.
Over the past week, the price has changed by +0.84%, over one month by +0.78%, over three months by -5.59% and over the past year by -31.50%.
Over the past week, the price has changed by +0.84%, over one month by +0.78%, over three months by -5.59% and over the past year by -31.50%.
Is RNO a buy, sell or hold?
Renault has no consensus analysts rating.
What are the forecasts/targets for the RNO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 41 | 26.5% |
| Analysts Target Price | - | - |
RNO Fundamental Data Overview February 25, 2026
Market Cap USD = 10.98b (9.28b EUR * 1.1832 EUR.USD)
P/E Forward = 6.5574
P/S = 0.1602
P/B = 0.5217
P/EG = 0.8055
Revenue TTM = 114.15b EUR
EBIT TTM = -5.93b EUR
EBITDA TTM = 28.65b EUR
Long Term Debt = 4.86b EUR (from longTermDebt, last quarter)
Short Term Debt = 60.18b EUR (from shortTermDebt, last quarter)
Debt = 70.08b EUR (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 50.06b EUR (calculated as Total Debt 70.08b - CCE 20.01b)
Enterprise Value = 59.34b EUR (9.28b + Debt 70.08b - CCE 20.01b)
Interest Coverage Ratio = -10.90 (Ebit TTM -5.93b / Interest Expense TTM 544.0m)
EV/FCF = 15.45x (Enterprise Value 59.34b / FCF TTM 3.84b)
FCF Yield = 6.47% (FCF TTM 3.84b / Enterprise Value 59.34b)
FCF Margin = 3.36% (FCF TTM 3.84b / Revenue TTM 114.15b)
Net Margin = -8.83% (Net Income TTM -10.09b / Revenue TTM 114.15b)
Gross Margin = 18.89% ((Revenue TTM 114.15b - Cost of Revenue TTM 92.58b) / Revenue TTM)
Gross Margin QoQ = 18.88% (prev 17.69%)
Tobins Q-Ratio = 0.49 (Enterprise Value 59.34b / Total Assets 121.01b)
Interest Expense / Debt = 0.05% (Interest Expense 38.0m / Debt 70.08b)
Taxrate = 36.26% (198.0m / 546.0m)
NOPAT = -3.78b (EBIT -5.93b * (1 - 36.26%)) [loss with tax shield]
Current Ratio = 1.03 (Total Current Assets 90.71b / Total Current Liabilities 88.47b)
Debt / Equity = 3.37 (Debt 70.08b / totalStockholderEquity, last quarter 20.79b)
Debt / EBITDA = 1.75 (Net Debt 50.06b / EBITDA 28.65b)
Debt / FCF = 13.03 (Net Debt 50.06b / FCF TTM 3.84b)
Total Stockholder Equity = 25.37b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.30% (Net Income -10.09b / Total Assets 121.01b)
RoE = -39.75% (Net Income TTM -10.09b / Total Stockholder Equity 25.37b)
RoCE = -19.62% (EBIT -5.93b / Capital Employed (Equity 25.37b + L.T.Debt 4.86b))
RoIC = -3.96% (negative operating profit) (NOPAT -3.78b / Invested Capital 95.57b)
WACC = 0.95% (E(9.28b)/V(79.36b) * Re(7.89%) + D(70.08b)/V(79.36b) * Rd(0.05%) * (1-Tc(0.36)))
Discount Rate = 7.89% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.52%
[DCF] Terminal Value 88.43% ; FCFF base≈3.67b ; Y1≈4.52b ; Y5≈7.70b
[DCF] Fair Price = 601.2 (EV 224.32b - Net Debt 50.06b = Equity 174.25b / Shares 289.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -50.44 | EPS CAGR: -1.23% | SUE: 0.0 | # QB: 0
Revenue Correlation: 45.31 | Revenue CAGR: 6.53% | SUE: 0.02 | # QB: 0
EPS current Year (2026-12-31): EPS=7.01 | Chg7d=-0.245 | Chg30d=-0.375 | Revisions Net=-6 | Growth EPS=+117.5% | Growth Revenue=+2.1%
EPS next Year (2027-12-31): EPS=7.52 | Chg7d=-0.352 | Chg30d=-0.590 | Revisions Net=-4 | Growth EPS=+7.3% | Growth Revenue=+1.9%
[Analyst] Revisions Ratio: -0.75 (1 Up / 7 Down within 30d for Current Year)
P/E Forward = 6.5574
P/S = 0.1602
P/B = 0.5217
P/EG = 0.8055
Revenue TTM = 114.15b EUR
EBIT TTM = -5.93b EUR
EBITDA TTM = 28.65b EUR
Long Term Debt = 4.86b EUR (from longTermDebt, last quarter)
Short Term Debt = 60.18b EUR (from shortTermDebt, last quarter)
Debt = 70.08b EUR (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 50.06b EUR (calculated as Total Debt 70.08b - CCE 20.01b)
Enterprise Value = 59.34b EUR (9.28b + Debt 70.08b - CCE 20.01b)
Interest Coverage Ratio = -10.90 (Ebit TTM -5.93b / Interest Expense TTM 544.0m)
EV/FCF = 15.45x (Enterprise Value 59.34b / FCF TTM 3.84b)
FCF Yield = 6.47% (FCF TTM 3.84b / Enterprise Value 59.34b)
FCF Margin = 3.36% (FCF TTM 3.84b / Revenue TTM 114.15b)
Net Margin = -8.83% (Net Income TTM -10.09b / Revenue TTM 114.15b)
Gross Margin = 18.89% ((Revenue TTM 114.15b - Cost of Revenue TTM 92.58b) / Revenue TTM)
Gross Margin QoQ = 18.88% (prev 17.69%)
Tobins Q-Ratio = 0.49 (Enterprise Value 59.34b / Total Assets 121.01b)
Interest Expense / Debt = 0.05% (Interest Expense 38.0m / Debt 70.08b)
Taxrate = 36.26% (198.0m / 546.0m)
NOPAT = -3.78b (EBIT -5.93b * (1 - 36.26%)) [loss with tax shield]
Current Ratio = 1.03 (Total Current Assets 90.71b / Total Current Liabilities 88.47b)
Debt / Equity = 3.37 (Debt 70.08b / totalStockholderEquity, last quarter 20.79b)
Debt / EBITDA = 1.75 (Net Debt 50.06b / EBITDA 28.65b)
Debt / FCF = 13.03 (Net Debt 50.06b / FCF TTM 3.84b)
Total Stockholder Equity = 25.37b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.30% (Net Income -10.09b / Total Assets 121.01b)
RoE = -39.75% (Net Income TTM -10.09b / Total Stockholder Equity 25.37b)
RoCE = -19.62% (EBIT -5.93b / Capital Employed (Equity 25.37b + L.T.Debt 4.86b))
RoIC = -3.96% (negative operating profit) (NOPAT -3.78b / Invested Capital 95.57b)
WACC = 0.95% (E(9.28b)/V(79.36b) * Re(7.89%) + D(70.08b)/V(79.36b) * Rd(0.05%) * (1-Tc(0.36)))
Discount Rate = 7.89% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.52%
[DCF] Terminal Value 88.43% ; FCFF base≈3.67b ; Y1≈4.52b ; Y5≈7.70b
[DCF] Fair Price = 601.2 (EV 224.32b - Net Debt 50.06b = Equity 174.25b / Shares 289.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -50.44 | EPS CAGR: -1.23% | SUE: 0.0 | # QB: 0
Revenue Correlation: 45.31 | Revenue CAGR: 6.53% | SUE: 0.02 | # QB: 0
EPS current Year (2026-12-31): EPS=7.01 | Chg7d=-0.245 | Chg30d=-0.375 | Revisions Net=-6 | Growth EPS=+117.5% | Growth Revenue=+2.1%
EPS next Year (2027-12-31): EPS=7.52 | Chg7d=-0.352 | Chg30d=-0.590 | Revisions Net=-4 | Growth EPS=+7.3% | Growth Revenue=+1.9%
[Analyst] Revisions Ratio: -0.75 (1 Up / 7 Down within 30d for Current Year)